Once Novartis put out the word that it would start “consultations” about the future of its R&D site in Horsham, U.K., there was never much doubt that the pharma giant would go ahead and close the operation, putting the futures of some 400 staffers and 170 consultants in doubt. On Wednesday the pharma giant confirmed those expectations.

…read more

Source: Novartis to shutter R&D site in June as global reorganization unfolds


0 No comments